CHIMERE - Mother-to-Child Chikungunya virus infection: an ambispective cohort study ARCHIVE

Head :
Gérardin Patrick, Centre d'Investigation Clinique (CIC 1410) - ex Centre d'Investigation Clinique - Epidémiologie Clinique (CIE2)
Fritel Xavier, Service de Gynécologie-Obstétrique et Médecine de la Reproduction, CHU de Poitiers, Université de Poitiers, Faculté de Médecine et Pharmacie. http://medphar.univ-poitiers.fr/CESP UMR Inserm U1018, Equipe 7 : Genre, Santé Sexuelle et Reproductive.

Last update : 10/01/2018 | Version : 2 | ID : 23302

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Mother-to-Child Chikungunya virus infection: an ambispective cohort study
Sign or acronym CHIMERE
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL 1836406, CPP Tours 2006/2007
General Aspects
Medical area Infectious diseases
Keywords Chikungunya virus; pregnancy; obstetrics; perinatal medicine; mother; neonate; mother-to-child transmission; pediatrics; children; encephalitis; encephalopathy; neurodevelopmental outcome; sequelae; cohort studies
Scientific investigator(s) (Contact)
Name of the director Gérardin
Surname Patrick
Address Centre de Recherche Médicale et en Santé - CHU Réunion - Site du Groupe Hospitalier Sud Réunion - avenue du Président François Mitterrand - BP 350 - 97448 Saint Pierre Cedex - île de la Réunion
Phone + (262) 262.35.90.00 + 5.42.71 ; + (262) 262.35.90.00 + 5.83.94 ; + (262) 262.35.90.00 + 5.87.53
Email patrick.gerardin@chu-reunion.fr
Unit Centre d'Investigation Clinique (CIC 1410) - ex Centre d'Investigation Clinique - Epidémiologie Clinique (CIE2)
Organization CHU de La Réunion / Inserm /Université de La Réunion / Union Régionale des Médecins Libéraux de l'Océan
Name of the director Fritel
Surname Xavier
Address Gynécologue-Obstétricien, Service de Gynécologie-Obstétrique et Médecine de la Reproduction, CHU de Poitiers, 2 rue de la Milétrie, 86000 Poitiers, France
Phone + (33) 5.49.44.33.60. ; + (33) 5.49.44.39.45
Email xavier.fritel@univ-poitiers.fr
Unit Service de Gynécologie-Obstétrique et Médecine de la Reproduction, CHU de Poitiers, Université de Poitiers, Faculté de Médecine et Pharmacie. http://medphar.univ-poitiers.fr/CESP UMR Inserm U1018, Equipe 7 : Genre, Santé Sexuelle et Reproductive.
Organization 2224Inserm CIC-P 1402 Centre d’Investigation Clinique Plurithématique du CHU de Poitiers. http://cic0802.labo.univ-poitiers.fr
Collaborations
Participation in projects, networks and consortia Yes
Details Reacting network for the Chikungunya in French West Indies and Guyana
Funding
Funding status Public
Details PHRC grant 2006
Governance of the database
Sponsor(s) or organisation(s) responsible CHU de la Réunion
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Ambispective: prospective enrollement of consecutive mother-infant pairs from April, 2006 to November, 2006; retrospective enrollment of 33 additional mother-infant pairs whose child had been infected between June 2005 to April 2006.
Database objective
Main objective 1- Primary objective: to assess the prevalence and the neurodevelopmental outcomes of maternal-fetal chikungunya infection ; 2-Secundary objectives: to decipher the mechanisms and risk factors of mother-to-child chikungunya virus transmission; to describe the chikungunya virus in the pregnant woman and in the neonate;
to propose a guideline for diagnosis and treatment of infections over pregnancy, childbirth and neonatal periods; to valid the virological diagnosis in the neonate using cord blood RT-PCRs; to study viral strains; to describe in children exposed in utero to maternal infection the kinetics of seroreversion of maternal transplacental IgG antibodies.
Inclusion criteria Maternal study: pregnant women with life insurance cover; Child study: children born from women enrolled in t the maternal cohort. Inclusion whatever the pregnancy story and the exposure the first two months, then only the exposed women reporting a chikungunya attack the next six following months.
Population type
Age Newborns (birth to 28 days)
Infant (28 days to 2 years)
Population covered General population
Gender Woman
Geography area Departmental
French regions covered by the database La Réunion
Detail of the geography area Cohort study conducted in four public maternities: Saint Denis, Saint Louis, Saint Paul, Saint Pierre; one semi-public semi-private maternity: Saint Benoît; one private maternity: Sainte Clotilde
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 06/2005
Date of last collection (YYYY or MM/YYYY) 10/2008
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 1433
Data
Database activity Data collection completed
Type of data collected Clinical data
Declarative data
Paraclinical data
Biological data
Administrative data
Clinical data (detail) Direct physical measures
Medical registration
Details of collected clinical data Mothers: inclusions, clinical examinations and anthropometric measures during pregnancy and/or at childbirth. Children: inclusions and clinical examinations and anthropometric measures at birth, 9-12 months (CLAMS and babyvision), 18-24 months (revised Brunet-Lezine DQ)
Declarative data (detail) Face to face interview
Details of collected declarative data Mothers: inclusions, clinical examinations and anthropometric measures during pregnancy and/or at childbirth. Children: inclusions and clinical examinations and anthropometric measures at birth, 9-12 months (CLAMS and babyvision), 18-24 months (revised Brunet-Lezine DQ)
Paraclinical data (detail) Mothers: virological and serological examinations during pregnancy and/or at childbirth. Children: virological and serological examinations at birth, then serological examinations exclusively at 3 weeks, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months.
Biological data (detail) Mothers: blood numeration and formula at childbirth; children: blood numeration and formula at birth
Administrative data (detail) Hospital stays
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Data collected by hospital-based gynecologists-obstetricians, midwives, neonatologists-pediatricians, psychometrists, neuropsychologists in CAMSP centers at the different time-points of follow-up (see above).
Participant monitoring Yes
Details on monitoring of participants Children: clinical examinations and anthropometric measures at birth by neonatologists-pediatricians at 9-12 months (CLAMS and babyvision by pyschometrists), at 18-24 months (revised Brunet-Lezine DQ by blind neuropsychologist of the infectious status);Serological examinations at 3 weeks, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months.
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://www.sciencedirect.com/science/article/pii/S1201971208001586
Link to the document http://wwwnc.cdc.gov/eid/article/16/3/pdfs/09-1403.pdf
Link to the document http://tinyurl.com/HAL-CHIMERE
Description List of publications in HAL
Link to the document http://tinyurl.com/Pubmed-CHIMERE
Description List of publications in Pubmed
Access
Terms of data access (charter for data provision, format of data, availability delay) modalities of access to the database in progress.
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05